Protease-Activated Receptor 1 as Therapeutic Target in Breast, Lung, and Ovarian Cancer: Pepducin Approach

por Covic, Lidija, Kuliopulos, Athan
Publicado 2018

A matrix metalloprotease-PAR1 system regulates vascular integrity, systemic inflammation and death in sepsis

por Tressel, Sarah L, Kaneider, Nicole C, Kasuda, Shogo, Foley, Caitlin, Koukos, Georgios, Austin, Karyn, Agarwal, Anika, Covic, Lidija, Opal, Steven M, Kuliopulos, Athan
Publicado 2011

PAR1 (Protease-Activated Receptor 1) Pepducin Therapy Targeting Myocardial Necrosis in Coronary Artery Disease and Acute Coronary Syndrome Patients Undergoing Cardiac Catheterizati...

por Kuliopulos, Athan, Gurbel, Paul A., Rade, Jeffrey J., Kimmelstiel, Carey D., Turner, Susan E., Bliden, Kevin P., Fletcher, Elizabeth K., Cox, Daniel H., Covic, Lidija
Publicado 2020

PAR2 controls cholesterol homeostasis and lipid metabolism in nonalcoholic fatty liver disease

por Rana, Rajashree, Shearer, Andrew M., Fletcher, Elizabeth K., Nguyen, Nga, Guha, Srijoy, Cox, Daniel H., Abdelmalek, Manal, Wang, Ying, Baleja, James D., Covic, Lidija, Kuliopulos, Athan
Publicado 2019